This article provides an overview of clinical data warehousing and its historical perspective from the early 1990s to present. It uses a survey of five Houston-area healthcare leaders to answer questions such as why commercially available solutions may be more suitable as their enterprise information systems vs. developing them in-house. Which products and vendors are servicing these organizations? What are these organizations looking for when making such strategic purchases? In general, this work is intended as a guideline for healthcare entities to further investigate the commercial clinical data warehousing market and get a feel for industry trends.
Download full-text PDF |
Source |
---|
Sci Total Environ
January 2025
Institute for Marine and Antarctic Studies, University of Tasmania, Hobart, Australia; CSIRO Environment, Hobart, Australia.
Ingestion of plastic can have negative health consequences for wildlife. However, our understanding of the physiological impacts of plastics is limited, often relying on opportunistic sampling. We partnered with Tasmanian Aboriginal seabird harvesters, wildlife rescue clinics, and parks managers, to collect >400 fledgling yula/short-tailed and flesh-footed shearwaters across a spectrum of body conditions.
View Article and Find Full Text PDFLung Cancer
January 2025
Dept. of Medical Oncology, Princess Margaret Cancer Center, Toronto, ON, Canada.
Background: Manual extraction of real-world clinical data for research can be time-consuming and prone to error. We assessed the feasibility of using natural language processing (NLP), an AI technique, to automate data extraction for patients with advanced lung cancer (aLC). We assessed the external validity of our NLP-extracted data by comparing our findings to those reported in the literature.
View Article and Find Full Text PDFLung Cancer
January 2025
Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
Objectives: The lack of definitive biomarkers presents a significant challenge for chemo-immunotherapy in extensive-stage small-cell lung cancer (ES-SCLC). We aimed to identify key genes associated with chemo-immunotherapy efficacy in ES-SCLC through comprehensive gene expression analysis using machine learning (ML).
Methods: A prospective multicenter cohort of patients with ES-SCLC who received first-line chemo-immunotherapy was analyzed.
Drug Metab Pharmacokinet
November 2024
Clinical Research, Drug Development Division, Sumitomo Pharma Co., Ltd., 33-94, Enoki-cho, Suita, Osaka, 564-0053, Japan. Electronic address:
The second-generation antipsychotic blonanserin is a highly selective, full antagonist of dopamine D and D and serotonin 5-HT receptors. It is currently prescribed for patients with schizophrenia in Japan. We aimed to develop a population pharmacokinetic model of oral blonanserin, including data from 12 to 77 years old patients, to assess the covariates that influence blonanserin pharmacokinetics and evaluate appropriate dosage regimens in adolescents versus adults.
View Article and Find Full Text PDFActa Pharm
December 2024
Department of Clinical Pharmacy, University Hospital Dubrava, 10000 Zagreb Croatia.
Cardiovascular diseases (CVDs) are the leading cause of mortality and morbidity globally. It is estimated that 17.9 million people died from CVDs in 2019, which represents 32 % of all deaths worldwide.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!